TORRENT PHARMACEUTICALS LTD. - 500420 - Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Outcome of Board Meeting dated 27-Jul-202127-07-2021
27-07-2021
Torrent Pharmaceuticals Ltd - 500420 - Shareholding for the Period Ended June 30, 2021
Torrent Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here17-07-2021
Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 27th July, 2021 at 06:30 P.M. to discuss the financial performance of the Company for the quarter ended 30th June, 2021.17-07-2021
Buy Torrent Pharmaceuticals: target of Rs 3400: Sharekhan
Sharekhan is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated July 14, 2021.15-07-2021
Torrent Pharma Q1 PAT seen up 34.2% YoY to Rs 430.8 cr: KRChoksey
Net Sales are expected to decrease by 5.8 percent Y-o-Y to Rs 1,837 crore, according to KRChoksey.13-07-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share Certificate12-07-2021
Torrent Pharmaceuticals Ltd - 500420 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Mahesh AgrawalDesignation :- Company Secretary and Compliance Officer09-07-2021
Torrent Pharmaceuticals Ltd - 500420 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2021 ,inter alia, to consider and approve We would like to inform you that a meeting of the Board of Directors will be held on Tuesday, 27-Jul-21, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on 30-Jun-21.09-07-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the copies of Newspaper cuttings published in Financial Express (English) on 4th July, 2021 and Financial Express (Gujarati) on 5th July, 2021 in connection with the 48th Annual General Meeting and E-Voting Procedure.05-07-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Reg. 34 (1) Annual Report
Please find attached herewith soft copy of the Integrated Annual Report 2020-21 (comprising of Notice calling 48th Annual General Meeting (AGM) along with Audited Financial Statements, Directors'' Report, Auditors' Report, etc.) of Torrent Pharmaceuticals Limited in compliance with Regulation 34(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201502-07-2021